1-4 of 4
Andreas W. Schreiber
Close
Sort by
Journal Articles

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1 , GATA2 , and DDX41

Claire C. Homan, Michael W. Drazer, Kai Yu, David M. Lawrence, Jinghua Feng, Luis Arriola-Martinez, Matthew J. Pozsgai, Kelsey E. McNeely, Thuong Ha, Parvathy Venugopal, Peer Arts, Sarah L. King-Smith, Jesse Cheah, Mark Armstrong, Paul Wang, Csaba Bödör, Alan B. Cantor, Mario Cazzola, Erin Degelman, Courtney D. DiNardo, Nicolas Duployez, Remi Favier, Stefan Fröhling, Ana Rio-Machin, Jeffery M. Klco, Alwin Krämer, Mineo Kurokawa, Joanne Lee, Luca Malcovati, Neil V. Morgan, Georges Natsoulis, Carolyn Owen, Keyur P. Patel, Claude Preudhomme, Hana Raslova, Hugh Rienhoff, Tim Ripperger, Rachael Schulte, Kiran Tawana, Elvira Velloso, Benedict Yan, Erika Kim, Raman Sood, Amy P. Hsu, Steven M. Holland, Kerry Phillips, Nicola K. Poplawski, Milena Babic, Andrew H. Wei, Cecily Forsyth, Helen Mar Fan, Ian D. Lewis, Julian Cooney, Rachel Susman, Lucy C. Fox, Piers Blombery, Deepak Singhal, Devendra Hiwase, Belinda Phipson, Andreas W. Schreiber, Christopher N. Hahn, Hamish S. Scott, Paul Liu, Lucy A. Godley, Anna L. Brown
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6092–6107.
https://doi.org/10.1182/bloodadvances.2023010045
Published: 2023
Includes: Supplemental data
Journal Articles

Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations

Clinical Trials & Observations
Michael W. Drazer, Claire C. Homan, Kai Yu, Marcela Cavalcante de Andrade Silva, Kelsey E. McNeely, Matthew J. Pozsgai, Maria G. Acevedo-Mendez, Jeremy P. Segal, Peng Wang, Jinghua Feng, Sarah L. King-Smith, Erika Kim, Sophia Korotev, David M. Lawrence, Andreas W. Schreiber, Christopher N. Hahn, Hamish S. Scott, Raman Sood, NISC Comparative Sequencing Program, Elvira D. R. P. Velloso, Anna L. Brown, Paul P. Liu, Lucy A. Godley
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4357–4359.
https://doi.org/10.1182/bloodadvances.2022007211
Published: 2022
Includes: Supplemental data
Journal Articles

RUNX1 -mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML

Anna L. Brown, Peer Arts, Catherine L. Carmichael, Milena Babic, Julia Dobbins, Chan-Eng Chong, Andreas W. Schreiber, Jinghua Feng, Kerry Phillips, Paul P. S. Wang, Thuong Ha, Claire C. Homan, Sarah L. King-Smith, Lesley Rawlings, Cassandra Vakulin, Andrew Dubowsky, Jessica Burdett, Sarah Moore, Grace McKavanagh, Denae Henry, Amanda Wells, Belinda Mercorella, Mario Nicola, Jeffrey Suttle, Ella Wilkins, Xiao-Chun Li, Joelle Michaud, Peter Brautigan, Ping Cannon, Meryl Altree, Louise Jaensch, Miriam Fine, Carolyn Butcher, Richard J. D’Andrea, Ian D. Lewis, Devendra K. Hiwase, Elli Papaemmanuil, Marshall S. Horwitz, Georges Natsoulis, Hugh Y. Rienhoff, Jr, Nigel Patton, Sally Mapp, Rachel Susman, Susan Morgan, Julian Cooney, Mark Currie, Uday Popat, Tilmann Bochtler, Shai Izraeli, Kenneth Bradstock, Lucy A. Godley, Alwin Krämer, Stefan Fröhling, Andrew H. Wei, Cecily Forsyth, Helen Mar Fan, Nicola K. Poplawski, Christopher N. Hahn, Hamish S. Scott
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1131–1144.
https://doi.org/10.1182/bloodadvances.2019000901
Published: 2020
Includes: Supplemental data
Journal Articles

ASXL1 and BIM germ line variants predict response and identify CML patients with the greatest risk of imatinib failure

Clinical Trials & Observations
Justine E. Marum, David T. Yeung, Leanne Purins, John Reynolds, Wendy T. Parker, Doris Stangl, Paul P. S. Wang, David J. Price, Jonathan Tuke, Andreas W. Schreiber, Hamish S. Scott, Timothy P. Hughes, Susan Branford
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1369–1381.
https://doi.org/10.1182/bloodadvances.2017006825
Published: 2017
Includes: Supplemental data